Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

January 31, 2005

Study Completion Date

September 30, 2005

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

carboplatin

DRUG

cereport

RADIATION

radiation therapy

Trial Locations (19)

10032

Herbert Irving Comprehensive Cancer Center, New York

10461

Albert Einstein Clinical Cancer Center, The Bronx

13210

State University of New York - Upstate Medical University, Syracuse

15213

Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

55905

Mayo Clinic Cancer Center, Rochester

70112

MBCCOP - LSU Health Sciences Center, New Orleans

77030

Baylor College of Medicine, Houston

94304

Lucile Packard Children's Hospital at Stanford, Palo Alto

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

90027-0700

Children's Hospital Los Angeles, Los Angeles

94143-0128

UCSF Comprehensive Cancer Center, San Francisco

20010-2970

Children's National Medical Center, Washington D.C.

46202-5289

Indiana University Cancer Center, Indianapolis

02115

Dana-Farber Cancer Institute, Boston

39216-4505

University of Mississippi Medical Center, Jackson

45229-3039

Children's Hospital Medical Center - Cincinnati, Cincinnati

97201-3098

Doernbecher Children's Hospital, Portland

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00005602 - Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas | Biotech Hunter | Biotech Hunter